CRISPR/Cas genome editing technology was used to generate a 1 bp deletion of genomic sequences in the Slc38a11 gene, resulting in early termination after amino acid residue #35. (J:293042)
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count